As ViaLase nears commercial launch, the leadership change highlights its focus on market execution and global expansion.
Glaucoma research will be led by Ike Ahmed, MD, FRCSC, Fiona McDonnell, PhD, and Ian Pitha, MD, PhD.
The company appointed Tom Frinzi as executive chairman of the board, Richard Lewis, M.D., as chief medical officer, and Shawn O'Neil as chief commercial officer.
Dr. Juhasz and fellow LASIK researchers were recognized for scientific breakthroughs that led to the development of bladeless LASIK—an innovation that is now the standard of...
Get the most important news and business ideas for eyecare professionals every weekday from INVISION.
Advertisement
